title: Efficacy of cilofungin therapy administered by continuous intravenous infusion for experimental disseminated candidiasis in rabbits.
abstract: Cilofungin has potent in vitro activity against Candida albicans, but previous in vivo models using twice daily intermittent dosing regimens have not consistently demonstrated in vivo efficacy. Because of the pharmacokinetics of cilofungin in rabbits, it has been suggested that administration by continuous intravenous infusion might be more effective. We compared the in vivo efficacy of continuous intravenous infusion of cilofungin with that of amphotericin B in a rabbit model of disseminated candidiasis. Cilofungin prepared as previously described in phosphate-buffered 33% polyethylene glycol was lethal to infected rabbits in this model, as was phosphate-buffered 33% polyethylene glycol alone. In contrast, cilofungin in 26% polyethylene glycol and sterile water administered by continuous intravenous infusion was tolerated by rabbits, was significantly more effective than amphotericin therapy in reducing candida colony counts in kidney tissue, and was as effective as amphotericin therapy in lung and spleen tissue and in cardiac valvular vegetations. The dosage regimen and diluent used in some previous studies may have adversely affected outcome of treatment with cilofungin.
authors.affiliation: Infectious Diseases Research Laboratory, Mayo Clinic, Rochester, Minnesota 55905.
authors.forename: M S
authors.initials: MS
authors.lastname: Rouse
authors.forename: B M
authors.initials: BM
authors.lastname: Tallan
authors.forename: J M
authors.initials: JM
authors.lastname: Steckelberg
authors.forename: N K
authors.initials: NK
authors.lastname: Henry
authors.forename: W R
authors.initials: WR
authors.lastname: Wilson
mesh_terms: D000666:Amphotericin B / Q000097:blood / Q000627:therapeutic use*; D000818:Animals; D000935:Antifungal Agents / Q000008:administration & dosage / Q000627:therapeutic use*; D002177:Candidiasis / Q000188:drug therapy* / Q000401:mortality; D054714:Echinocandins; D007262:Infusions, Intravenous; D007668:Kidney / Q000469:parasitology; D008168:Lung / Q000469:parasitology; D010455:Peptides / Q000008:administration & dosage / Q000097:blood / Q000627:therapeutic use; D010456:Peptides, Cyclic; D011817:Rabbits; D013154:Spleen / Q000469:parasitology
chemical_list: D000935:Antifungal Agents; D054714:Echinocandins; D010455:Peptides; D010456:Peptides, Cyclic; D000666:Amphotericin B; C042101:cilofungin